Patents Assigned to Science Research Council
-
Patent number: 6525243Abstract: A method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division. The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time. The diploid nucleus can be donated by a cell in either the G0 or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor such as nocodazole. The reconstituted embryo may then give rise to one or more live animal births. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.Type: GrantFiled: August 29, 2000Date of Patent: February 25, 2003Assignees: Roslin Institute, The Minister of Agricultural, Fisheries and Food, Biotechnology & Biological Sciences Research CouncilInventors: Keith Henry Stockman Campbell, Ian Wilmut
-
Patent number: 6252133Abstract: A method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division. The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time. The diploid nucleus can be donated by a cell in either the G0 or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor such as nocodazole. The reconstituted embryo may then give rise to one or more live animal births. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.Type: GrantFiled: February 19, 1997Date of Patent: June 26, 2001Assignees: Roslin Institute (Edinburgh), The Minister of Agriculture, Fisheries & Food, Biotechnology & Biological Sciences Research CouncilInventors: Keith Henry Stockman Campbell, Ian Wilmut
-
Patent number: 6147276Abstract: A method of reconstituting a mammalian embryo involves transferring the nucleus from a quiescent donor cell into a suitable recipient cell. The donor cell is quiescent, in that it is caused to exit from the growth and division cycle at G1 and to arrest in the G0 state. Nuclear transfer may take place by cell fusion. The reconstituted embryo may then give rise to one or more mammals. The invention is useful in the production of transgenic mammals as well as non-transgenics of high genetic merit.Type: GrantFiled: February 19, 1997Date of Patent: November 14, 2000Assignees: Roslin Institute (Edinburgh), The Minister of Agriculture, Fisheries & Food, Biotechnology & Biological Sciences Research CouncilInventors: Keith Henry Stockman Campbell, Ian Wilmut
-
Patent number: 6100056Abstract: An organism which does not express its natural nisA gene product, but is capable of expressing genes for nisin modification, immunity and translocation out of the cell. The organism may be transformed with a coding sequence for a variant prenisin and appropriate regulatory sequences for expression thereof such that the organism is capable of secreting the corresponding variant nisin. A process for exclusively producing a variant nisin comprises fermenting this organism and obtaining the nisin so produced.Type: GrantFiled: December 24, 1996Date of Patent: August 8, 2000Assignee: Biotechnology and Biological Sciences Research CouncilInventors: Michael John Gasson, Helen Mair Dodd
-
Patent number: 5843453Abstract: Antigenic molecules cause antibodies to be raised against at least some of the 91 to 102 region of a natural growth hormone when parenterally administered in vivo. The molecules can include portions of the 91 to 102 region, particularly the 94 to 98 region. The antibodies are believed to bind to growth hormone on administration and enhance its effect.Type: GrantFiled: April 25, 1995Date of Patent: December 1, 1998Assignee: Biotechnology and Biological Sciences Research CouncilInventors: Andrew Thomas Holder, James Beattie
-
Patent number: 5643779Abstract: The nucleic acid coding for an .alpha.-acetolactate synthase from Lactococcus is provided, as well as vectors containing this nucleic acid and the use of these vectors for transforming microorganisms in which the production of .alpha.-acetolactate will be promoted, The nucleic acid comprises one or the other or both of a first segment corresponding to the ilvB gene (which encodes one subunit of .alpha.-acetolactate synthase of Lactococcus lactis subsp. lactis) and a second segment corresponding to the ilvN gene (which encodes a second subunit of .alpha.-acetolactate synthase of Lactococcus lactis subsp. lactis).Type: GrantFiled: July 21, 1995Date of Patent: July 1, 1997Assignee: Biotechnology and Biological Sciences Research CouncilInventors: Stanislav Ehrlich, Jean-Jacques Godon, Pierre Renault
-
Patent number: 4032810Abstract: An accelerating tube for an electrostatic particle accelerator is composed of a plurality of rings of insulating material interleaved with annular metal discs. The discs are interconnected externally of the tube by resistor bridges in a manner to provide a decoupled zone somewhere along the potential gradient and within this zone particle trapping electrodes are placed to take out low energy particles near the periphery of the main beam with reduced secondary particle generation.Type: GrantFiled: September 5, 1975Date of Patent: June 28, 1977Assignee: Science Research CouncilInventors: Derek Anthony Eastham, Thomas Joy
-
Patent number: 3952214Abstract: An electrostatic generator comprises a series of smooth uncovered electrically conductive elements which are interconnected mechanically by links so as to form an endless chain for carrying charge to a high voltage terminal. Electrical insulation by which each of the elements is insulated from its neighbours is arranged to be stressed in compression so as to take advantage of the better compressive properties generally exhibited by appropriate insulating materials. The elements may be elongated and arranged transversely of the travel of the chain, such that the chain resembles a caterpillar track.Type: GrantFiled: May 12, 1975Date of Patent: April 20, 1976Assignee: Science Research CouncilInventor: Thomas Wilson Aitken